PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 168 filers reported holding PTC THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $17,106,000 | -11.8% | 1,567,925 | +13.2% | 0.00% | -25.0% |
Q3 2016 | $19,398,000 | +112.6% | 1,384,550 | +6.5% | 0.00% | +100.0% |
Q2 2016 | $9,123,000 | +14.1% | 1,299,528 | +4.7% | 0.00% | 0.0% |
Q1 2016 | $7,993,000 | -79.9% | 1,241,219 | +1.1% | 0.00% | -77.8% |
Q4 2015 | $39,775,000 | +14.2% | 1,227,626 | -5.9% | 0.01% | 0.0% |
Q3 2015 | $34,840,000 | -42.2% | 1,304,857 | +4.2% | 0.01% | -35.7% |
Q2 2015 | $60,254,000 | -10.8% | 1,251,897 | +12.7% | 0.01% | -12.5% |
Q1 2015 | $67,579,000 | +19.8% | 1,110,576 | +1.9% | 0.02% | +14.3% |
Q4 2014 | $56,398,000 | +42.7% | 1,089,388 | +21.3% | 0.01% | +27.3% |
Q3 2014 | $39,513,000 | +67.3% | 897,814 | -0.7% | 0.01% | +57.1% |
Q2 2014 | $23,625,000 | +33.9% | 903,795 | +33.9% | 0.01% | +40.0% |
Q1 2014 | $17,645,000 | +88.8% | 675,013 | +22.6% | 0.01% | +66.7% |
Q4 2013 | $9,344,000 | +60.7% | 550,612 | +103.2% | 0.00% | +50.0% |
Q3 2013 | $5,815,000 | – | 270,961 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
Chubb Ltd | 8,180 | $393,000 | 1.68% |